Table 1.
Characteristics of the study participants.
| Variable | Controls (n = 26) |
Obese (n = 88) |
|---|---|---|
| Age (years) | 39.96 ± 7.07 | 38.15 ± 5.55 |
| Height (cm) | 164.58 ± 7.35 | 163.96 ± 6.22 |
| Body weight (kg) | 72.25 ± 13.83 | 87.98 ± 9.66 *** |
| BMI (kg/m2) | 26.33 ± 3.32 | 33.05 ± 2.17 *** |
| WHR | 0.837 ± 0.07 | 0.875 ± 0.06 * |
| Systolic blood pressure (mmHg) | 127.71 ± 19.00 | 125.56 ± 17.22 |
| Diastolic blood pressure (mmHg) | 82.29 ± 9.67 | 82.19 ± 8.19 |
| Fat mass (%) | 32.92 ± 5.38 | 37.78 ± 3.21 *** |
| Fat mass (kg) | 25.12 ± 8.24 | 34.59 ± 6.62 *** |
| Free fat mass (kg) | 47.13 ± 9.75 | 52.22 ± 4.96 *** |
| Total Cholesterol (mg/dL) | 190.42 ± 30.97 | 209.83 ± 36.52 * |
| HDL cholesterol (mg/dL) | 60.23 ± 10.34 | 58.86 ± 15.26 |
| LDL cholesterol (mg/dL) | 110.85 ± 29.14 | 128.17 ± 32.92 * |
| Triglycerides (mg/dL) | 93.93 ± 29.14 | 113.23 ± 48.40 |
| Total Cholesterol/HDL cholesterol | 3.14 ± 0.66 | 3.88 ± 1.30 * |
| Triglycerides/HDL cholesterol | 2.07 ± 1.35 | 2.13 ± 1.20 |
| Glucose (mg/dL) | 84.20 ± 8.58 | 88.12 ± 8.49 * |
| Insulin (mU/mL) | 8.91 ± 2.59 | 11.63 ± 5.20 |
| HOMA | 1.92 ± 0.60 | 2.53 ± 1.19 |
| Apolipoprotein AI (mg/dL) | 163.30 ± 18.34 | 159.55 ± 30.09 |
| CRP-hs (mg/L) | 1.57 ± 0.96 | 3.94 ± 3.51 *** |
| DNA damage (%) | 2.37 ± 0.64 | 5.13 ± 2.46 *** |
Data are presented as mean ± SD: standard deviation. BMI: body mass index; WHR: waist-hip-ratio; HOMA: Homeostasis Model Assessment; CRP-hs: C-reactive protein high sensitivity; HDL cholesterol: high density lipoprotein cholesterol; LDL cholesterol: low density lipoprotein cholesterol. Statistical analysis was performed with Mann-Whitney U-test. * p < 0.05; ** p < 0.001; *** p < 0.0001.